Opioid Abuse Identification and Treatment: Matthew's Story

Estimated time to complete session: 75 mins.

Learning Objectives

Upon completion of this session, you should be able to:

1. Summarize the impact of the opioid epidemic of prescription opioids, illicit opioids (i.e., heroin, illicitly manufactured fentanyl, etc.).

2. Explain the DSM-5 criteria for opioid use disorder diagnosis.

3. Identify patients for whom naloxone coprescription and training is recommended.

4. Outline the options for medication-assisted treatment for patients with opioid dependence.

5. Describe the steps and requirements to obtain the waiver to enable treatment of patients with buprenorphine for opioid use disorder. 

Additional Information

Technical Requirements: 

View technical requirements (opens in a new window).

CME Credit Information: 

View CME credit information (opens in a new window).

AAFP Staff: 
Disclosures: 

View disclosures and disclaimers (opens in a new window).

Course summary
Available credit: 
  • 1.25 AAFP prescribed
Course opens: 
03/25/2014
Course expires: 
03/05/2022

Tim Brown, PharmD, BCACP, FASHP – Director of Clinical Pharmacotherapy in Family Medicine, Center for Family Medicine at Akron General Medical Center, Cleveland Clinic Foundation Affiliate, Akron, Ohio

Available Credit

  • 1.25 AAFP prescribed

Accreditation Period

Course opens: 
03/25/2014
Course expires: 
03/05/2022
Please login or register to take this course.